Newsroom homepage
-
Press ReleasesCMS Proposed Rule Seeks Feedback on Staffing Standards and Health Equity
-
Press Releases
Ensuring the availability of innovative interventions for people is a shared priority for both the Centers for Medicare & Medicaid Services (CMS) and the U.S. Food and Drug Administration (FDA). We recognize the important and related – but different – roles of our respective
-
Fact Sheets
CMS is announcing a final Medicare national coverage determination (NCD) that covers Food and Drug Administration (FDA) approved monoclonal antibodies directed against amyloid for the treatment of Alzheimer’s disease (AD) when furnished in accordance to the Coverage Criteria
-
Press ReleasesDecision Follows Robust Stakeholder Input and Creates Pathway for Enhanced Access and Coverage of Drugs that Receive Traditional FDA Approval
-
Press ReleasesActions continue to protect the health and safety of nursing home residents
-
News Alert
Today, the Centers for Medicare & Medicaid Services (CMS) announced it will pay for a second COVID-19 booster shot of either the Pfizer-BioNTech or Moderna COVID-19 vaccines without cost sharing as it continues to provide coverage for this critical protection from the virus